The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Shakira Grant, MBBS, MSCR, Founder and CEO of CROSS Global Research & Strategy, LLC, will present “AI Impacting Pathology and Treatment Decisions” on October 13, 2026, from 1:00–1:30 PM CST.
Registration is free and open to the public. Register at https://soho.click/community-oncology-series
Leave feedback about this